Targeted brain delivery of RVG29‐modified rifampicin‐loaded nanoparticles for Alzheimer's disease treatment and diagnosis
Abstract Alzheimer's disease (AD) is an aging‐related neurodegenerative disease. The main pathological features of AD are β‐amyloid protein (Aβ) deposition and tau protein hyperphosphorylation. Currently, there are no effective drugs for the etiological treatment of AD. Rifampicin (RIF) is a se...
Saved in:
Main Authors: | Ruiyi Zhou (Author), Lihong Zhu (Author), Zhaohao Zeng (Author), Rixin Luo (Author), Jiawei Zhang (Author), Rui Guo (Author), Lei Zhang (Author), Qunying Zhang (Author), Wei Bi (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery
by: Rubin Hao, et al.
Published: (2020) -
Targeting Small Molecule Delivery to the Brain and Spinal Cord via Intranasal Administration of Rabies Virus Glycoprotein (RVG29)-Modified PLGA Nanoparticles
by: Eugene P. Chung, et al.
Published: (2020) -
Brain-targeted delivery of PEGylated nano-bacitracin A against Penicillin-sensitive and -resistant Pneumococcal meningitis: formulated with RVG29 and Pluronic® P85 unimers
by: Wei Hong, et al.
Published: (2018) -
Rifampicin-Loaded Mesoporous Silica Nanoparticles for the Treatment of Intracellular Infections
by: Santhni Subramaniam, et al.
Published: (2019) -
A Comparison of X-ray Absorption in Thyroid and Lens by Conventional Radiography and RVG
by: Sefid Poor E, et al.
Published: (1999)